Review Article
Advances in Understanding Mitochondrial MicroRNAs (mitomiRs) on the Pathogenesis of Triple-Negative Breast Cancer (TNBC)
Table 1
Roles and mechanisms of mitomiRs in metabolic reprogramming.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(+): oncogenic; (-): tumor suppressor; “↑”: enhanced; “↓”: reduced; ΔΨm: mitochondrial membrane potential; AASDHPPT: 4-phosphopantetheinyl transferase; ACACA: acetyl-CoA carboxylase; AGR2: anterior gradient 2; [Ca2+]m: mitochondrial calcium; AMPK: AMP-activated protein kinase; CAB39L: calcium-binding protein 39-like; C/EBPβ: CCAAT-enhancer-binding protein β; CPT1C: carnitine palmitoyltransferase 1C; CTH: cystathionine gamma-lyase; CYGB: cytoglobin; ECAR: extracellular acidification rate; EMT: epithelial-mesenchymal transition; ERRα (encoded by ESRRA): estrogen-related receptor alpha; FASN: fatty acid synthase; FOXO3a: forkhead box O3; G6PD: glucose-6-phosphate dehydrogenase; GLUT1: glucose transporter 1; GPD1L: glycerol-3-phosphate dehydrogenase 1; HIF1A/HIF-1α: hypoxia-inducible factor 1-alpha; HK2: hexokinase 2; HMGCR: 3-hydroxy-3-methylglutaryl CoA reductase; INSR: insulin receptor; IRS1: insulin receptor substrate 1; LDHA: lactate dehydrogenase A; MCT1: monocarboxylate transporter 1; MCU: mitochondrial calcium uniporter; mtDNA: mitochondrial DNA; mt-ROS: mitochondrial reactive oxygen species; OCR: oxygen consumption rate; OXPHOS: oxidative phosphorylation; PFK: phosphofructokinase; PI3K: phosphoinositide 3-kinases; PKM2: pyruvate kinase M1/2; SCD: stearoyl-CoA desaturase; SESN1: sestrin-1; STAT3: signal transducers and activators of transcription 3; UQCC2: ubiquinol-cytochrome c reductase complex assembly factor 2; xCT (encoded by SLC7A11): cystine/glutamate transporter. |